


























































published: 18 December 2013
doi: 10.3389/fped.2013.00045
Reflections on five decades of the Fontan Kreutzer
procedure
Christián Kreutzer 1*, Jacqueline Kreutzer 2 and Guillermo O. Kreutzer 3
1 Congenital Heart Surgery, Posadas National Hospital and Austral University Hospital, Buenos Aires, Argentina
2 Cardiac Catheterization Laboratories, Pittsburgh Children’s Hospital, Pittsburgh, PA, USA
3 Pediatric Cardiac Surgery, Bazterrica Clinic, Buenos Aires, Argentina
Edited by:
Antonio Francesco Corno, University
Sains Malaysia, Malaysia
Reviewed by:
Yves Durandy, CCML, France
K. M. Das, King Fahad Medical City,
Saudi Arabia
Vladimiro Vida, University of Padua,
Italy
*Correspondence:
Christián Kreutzer , Congenital Heart
Surgery, Posadas National Hospital
and Austral University Hospital, Illia y
Marconi, El Palomar, Buenos Aires,
Argentina
e-mail: maxplus92@yahoo.com
The first successful total right heart bypass via atriopulmonary anastomosis (APA) were
reported in 1971 for patients with tricuspid atresia. At the Children’s Hospital of Buenos
Aires, the cohort of such procedures started in July, when the first fenestrated right heart
by pass was performed, with the interposition of a homograft between the right atrial
appendage and the main pulmonary artery. In the second patient, instead of placing a
homograft, the APA was achieved with the patient’s own pulmonary root harvested from
the outflow tract of the right ventricle. These techniques were soon replaced in 1978 with
the development of the direct valveless posterior APA. Since the very beginning the princi-
ple was that the right atrium only functions as a pathway rather than a pump (reason why
no inferior vena cava valves were ever used), and the diastolic properties of the systemic
ventricle regulate the only real “pump” of this system. The late hemodynamic problems
inherent of the APA diminished with modern surgical techniques like the lateral tunnel (LT)
or the extracardiac conduit (EC). In spite of the improvement in prognosis and quality of life
that the modern techniques have brought for univentricular hearts (UH), with the passing
of time, deterioration of this system is frequently seen, due to chronic low cardiac output,
elevated central venous pressure making heart transplantation the final stage of treatment.
Progressive increase in pulmonary vascular resistances and ventricular dysfunction result
in a decline in quality of life and survival. However, the timing of this occurrence is variable,
and many survivors enjoy today a satisfactory clinical status. The challenge is to develop a
better solution for UH, but in the mean time the Fontan Kreutzer palliation represents the
best and only surgical option. It is undoubtedly one of the triumphs of cardiac surgery in
congenital heart disease.
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HISTORY OF THE FIRST ATRIOPULMONARY CONNECTION
Innovation often results from an unsolved need, as the applica-
tion of new solutions to meet new requirements. In the early 70s,
our field achieved excellent survival for the most complex forms
of biventricular hearts by many centers in the world. However,
patients with univentricular hearts (UH) were typically palliated
with systemic to pulmonary shunts, pulmonary artery bandings,
and partial right heart by pass such as the classic Glenn shunts and
other variants (1–3). Therefore a hemodynamic “solution” for UH
that was already suggested (4) was required.
The first atriopulmonary anastomosis (APA) was performed
without awareness of the pioneer work done by Professor Fontan,
published in January 1971 (5). History shows multiple examples
of independent discoveries of the same scientific idea or invention
(6). Considerable work on multiple simultaneous discoveries has
been achieved by William Ogburn and Dorothy Thomas. They
established a list of 148 independently duplicated scientific and
technological discoveries. They suggested these discoveries became
virtually inevitable as knowledge accumulated within any given
society and the needs of that society caused attention to be directed
toward problems associated with meeting those needs. Similarly,
the need to find a solution for single ventricle physiology was
clearly there in the early 70s. In July of that same year (1971), a
moribund, severely cyanosed 3-year-old boy with tricuspid atresia
Ib, was admitted to the cardiology ward at the Ricardo Gutierrez
Children’s Hospital. He had severe systemic desaturation due to a
thrombosed right pulmonary artery due to a previous Waterston
shunt (Figure 1A). Contrary to Professor Fontan’s first patient for
whom two traditional surgical alternatives would have been avail-
able (a Blalock–Taussig Shunt or a Glenn procedure), the only
theoretical options for this patient were both innovative surgical
procedures: the APA (6) or enlargement of the ventricular septal
defect (7). It was decided to perform an APA, placing a homo-
graft between the right atrial appendage and the main pulmonary
artery without doing a Glenn procedure, without valve implan-
tation in the inferior vena cava. A 6 mm fenestration at the atrial
septum was deliberately left open. This first patient was presented
as a case report in August 1971 at a meeting of the Argentinean
Society of Cardiology (6) (Figure 1B). Certainly, this was the first
fenestrated total right heart by-pass ever performed in the world
(8), as stated in the original article: “The total or partial closure of
the foramen ovale is a subject of discussion. Although its partial
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FIGURE 1 | (A) Preoperative angiogram of our first patient showing occluded
right pulmonary artery. Only small flow is seen into the left pulmonary artery
(B) Postoperative angiogram demonstrates widely patent APA with
interposition of a homograft. Note there is a small atrial communication left
open, acting as a fenestration (F). (C) Schematic representation of the original
APA performed in this patient, communicated in J. Thorac. Cardiovasc. Surg.
closure provides a safety valve for the right atrium it also may cause
a certain degree of systemic desaturation” (Figure 1C).
Dr. Luis Becú (Figure 2A) who was a superb cardiac morphol-
ogist, noticed that in tricuspid atresia Ib the pulmonary valve is
most commonly anatomically normal. Therefore, in December
1971 in another patient with the same condition, it was decided
to perform the APA directly (Figure 2B) with the patient’s own
pulmonary root and valve (8), speculating on the possibility of
growth and prevention of calcification, following Mr. Ross’s guide-
lines (Figure 2C) on how to remove the pulmonary annulus from
the outflow tract of the right ventricle.
Discussions with Drs. Luis Becú and Alberto Rodríguez Coro-
nel (Head of the Cardiac Catheterization Laboratory) on those
days were about the following dilemma: is the right atrium func-
tioning as a pump as suggested by Professors Francis Fontan and
Viking Bjork (9) or is it just a pathway? The conclusion that the
right atrium lacked the tissue properties of a ventricular cham-
ber and therefore would never function as a pump was soon
achieved. Furthermore, Dr Rodriguez Coronel emphasized the
important role of the end diastolic properties of the main ventri-
cle, acting as a suction pump and therefore being the only pump
of the total right heart by pass system. Thus, the right atrium
would only function as a pathway and would never do so as a
ventricular pump.
Sir Magdi Yacoub, in London expanded the application of the
procedure to double outlet left ventricle, reporting in 1975 with
a homograft with valves in the superior vena cava and inferior
vena cava. Of interest, he performed in one of the patients of
his series presenting with subaortic stenosis what we wrongfully
call nowadays a Damus–Kaye–Stansel (a pulmonary to ascend-
ing aorta anastomosis) procedure for single ventricle and aortic
obstruction (10, 11). This concept was later re appraised by Dr.
William Norwood (12).
The initial experience with the APA was presented at the cen-
tennial celebration of the Toronto Sick Children’s Hospital in
1975 (13). It was emphasized the importance of “sinus rhythm to
reduce left atrial pressure to obtain a reasonable gradient (about
6 mmHg) between the right and left atrium,” and “the left heart
being normal.” Regarding the need for valves at the inferior vena
cava and “outlet” of right atrium it was stated that: “because of the
continuous venous flow we doubt that those valves would work
adequately and they could increase peripheral venous pressure
and the subsequent edema.” In this regard, Dr. Rodriguez Coro-
nel acknowledged that the pulmonary valve would be open in the
whole cardiac cycle, and only would close in the event of Valsalva
o coughing.
Finally, in 1978 it was clear that the interposition of a pul-
monary valve was deleterious in this system, even more if associ-
ated to obstruction (frequently seen in homografts placed in the
right side of the heart). Therefore, the surgical approach was com-
pletely changed: the concept of the largest posterior APA without
a valve was introduced, moving the pulmonary trunk to the right,
posteriorly and behind the aorta (Figure 3), avoiding the possi-
bility of sternal compression. This new approach was presented in
1980 in London (14) at World Congress of Pediatric Cardiology,
and published (Figure 4) in several journals (12, 15, 16).
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FIGURE 2 | (A) Morphologist Dr. Luis Becú showing that the pulmonary artery is usually normal in TA Ib. (B) APA with the patient own pulmonary valve
removed from the outflow tract of the right ventricle. (C) Mr. Donald Ross’s technique for the removal of the pulmonary annulus.
FIGURE 3 | Illustrations demonstrate the steps of the technique used
for the posterior APA developed in 1978 presented in London, 1980.
NORWOOD’S REVOLUTION AND DEVELOPMENT OF
IMPROVED SURGICAL TECHNIQUES
In the early 80s Dr. William Norwood at Children’s Hospital of
Boston and Philadelphia was confronting the biggest challenge in
congenital heart surgery: an operation for hypoplastic left heart
syndrome (17), a condition that was uniformly lethal at the time.
Not only Dr Norwood envisioned the procedure that allowed sur-
vival for such complex lesion, he also devised a staged pathway
of treatment for all forms of UH. Depending on the initial clin-
ical presentation a neonatal palliation, with a Modified Blalock–
Taussig Shunt (MBTS),a Norwood procedure or pulmonary artery
banding, as a first stage, a bidirectional Glenn or hemiFontan as a
second stage in infancy, and the total right heart by pass at 2/5 years
of age as a third stage.
The increasing survival of patients with single ventricle and
mitral atresia or stenosis, made the atriopulmonary connections
inadequate for such patients, since the need for complex atrial sep-
tations is mandatory in such scenario. Therefore, when years later,
in 1988,Marc de Leval at Great Ormond Street Hospital in London,
introduced the accurate concept of energy loss in a passive flow
system within a large right atrium (18, 19) and described the total
cavopulmonary connection (Figure 4A) his technique was widely
adopted. Aldo Castañeda with Dr. Lock and Dr. Bridges re intro-
duced the concept of a fenestration as part of the procedure (20)
(Figure 4B). Prior to this, in order to avoid complex atrial septa-
tion a similar technique had been performed by Dr. Francisco Puga
(21) and afterward, Drs Puga (22) and Marcelletti (23) developed
the extracardiac conduit technique (EC) (Figures 4C,D), which
is since 1997 most surgeons technique of choice for all patients.
It can be considered controversial to determine whether the lat-
eral tunnel (LT) or the EC is the best approach. Both techniques
have excellent outcomes (20). The approach is often dependent
on the preference of the cardiothoracic surgeon and team. It can
also be a source of discussion whether a bidirectional Glenn or a
hemiFontan is the best option.
Some differences should be pointed out between the staged LT
after a bidirectional Glenn versus a hemi-Fontan. When the LT
procedure is performed following a bidirectional Glenn preser-
vation of the sinus node and its artery is jeopardized (24). LT is
more frequently used in smallest patients commonly at the final
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FIGURE 4 | (A) De Leval’s total cavopulmonary connection (B) fenestrated lateral tunnel technique. (C) Puga´s extracardiac conduit technique (D) Marcelleti´s
extracardiac conduit technique.
stage of HLHS palliation (22, 23). However a weight less than 15 kg
do not preclude the performance of an EC. With the aid of deep
hypothermic circulatory arrest for the inferior anastomosis a large
conduit of 16–18 mm can be easily placed in a 1-year-old infant.
The EC has a favorable balance in “bigger” patients considering
the following advantages: (1) no intraatrial sutures (2) possibility
of performing EC without aortic cross clamp (3) the sinus node
and the crista terminalis area remains at low pressure and without
suture lines in the area, avoiding injury and subsequent arrhyth-
mias (23) (4) possibility of closing the fenestration without using
a device (25). (5) The EC is a cylinder (18–20 mm) with similar
inlet and outlet diameter, different than the LT that it is a truncated
cone which its base (the inferior vena cava is larger than the out-
let (the superior vena cava). For this reason, fenestration is more
necessary with its consequent device closure (26). The presence of
bilateral superior vena cava makes the mismatch more evident. In
this situation, the EC should be mandatory.
When a hemi-Fontan (27) or a staged LT are performed as the
superior vena cava is augmented with a pericardial patch, there
is higher risk of injury to the sinus node artery, given its peculiar
anatomy (28). It can course in the anterior aspect of the supe-
rior vena cava, or on the posterior one or all around it, encircling
it. On the other hand, the prosthetic tube of the EC does not
increase its diameter (problem for “small” patients), and finally it
requires extensive dissection and may induce phrenic nerve palsy
(29). The latter may be avoided by using total circulatory arrest,
without cannulation of caval veins. The risk of early thromboem-
bolism could be diminished avoiding central venous lines (29). The
use of a fenestrated EC with the skirt’s technique for fenestration
FIGURE 5 | Fenestration with the skirt’s technique with snare* for
deferred closing.
(Figure 5) (25) allows its closure before hospital discharge accord-
ing to the patient hemodynamics, by adjusting the snare under
local anesthesia, without needing a device.
EVOLUTION OF THE SUBOPTIMAL FONTAN KREUTZER
HEMODYNAMIC SYSTEM
The natural history of the univentricular heart without surgery
and with palliative procedures as shunts or bandings is disas-
trous. In spite of chronically limited cardiac output (30), the
Fontan Kreutzer procedure has improved significantly (31, 32)
the prognosis and quality of life. However, to live with only one
ventricle has some limitations as a consequence of high venous
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pressure in the limit of the peripheral edema and limited cardiac
output. The FK palliation represents without any doubt, the best
surgical approach that we could offer today for these lesions. With
the modern techniques, the late quality of life is remarkable, with
almost 75% of survivors in NYHA class 1, in addition to an exercise
tolerance of more than 60% of predicted value (31, 32).
In this matter it is quite remarkable that the Fontan Kreutzer
procedure is the only palliation that provides the univentricular
heart male patient the possibility of having a sexual life, since as a
general rule, only a male adult who completes the first two stages
of the Bruce protocol has a functional capacity >7 METs, which
is considered sufficient for sexual intercourse (33). The Fontan
Kreutzer procedure provides the vast majority of young adults
with UH a functional capacity of more than seven METs with a
mean and median close to 10 (30). On the contrary, a bidirectional
Glenn with accessory pulmonary blood flow suggested as a defin-
itive palliation by Professors Vohué and Sidi fails to provide a an
exercise capacity of more than six METs in most patients (34).
Pregnancy for patients with a Fontan circulation is more
likely to face obstetrical, rather than cardiovascular complications
(although a decline in the cardiovascular status is frequently seen in
the third trimester), including preterm labor, intrauterine growth
restriction, an increased risk of cesarean section, and the potential
need for anticoagulation (35).
Of note, we should be very cautious to refer to the classic articles
(36) on late follow up after Fontan Kreutzer procedures performed
prior 1990, and use these to predict late outcome of our current
patients. These represent the results of surgical strategies and pro-
cedures that are no longer in use (i.e., long standing pulmonary
artery bandings, classic right or left Blalock–Taussig shunts, late
intervention, late diagnosis of significant hemodynamic problems,
and inadequate surgical techniques such us the classic Fontan and
Kreutzer original operations) (Table 1).
But secondary to a multifactorial phenomenon (Table 1) it is
evident that a progressive decline in functional status appears in
many the FK survivors, who develop heart failure (30), arrhyth-
mias (37), thromboembolism (38), protein losing enteropathy
(39), plastic bronchitis (40), unexplained sudden deaths (41), and
hepatic failure (42, 43). The reality is that these problems occur
as patients do live to late follow up. Under the best circumstances
using the modern surgical techniques, at least 80% of patients
with single ventricle are alive after 20 years, following at least three
cardiac procedures (32).
For the late survivor with “old fashioned” Fontan Kreutzer con-
nections a conversion to LT or EC with concomitant arrhythmia
surgery is indicated only for symptomatic patients with sev-
eral episodes of arrhythmia in spite of amiodarone treatment or
thrombus in the right atrium following Mavroudis’s guidelines
(44). In failing APA the central tunnel technique may be considered
as well (45). However, when ventricular dysfunction is the main
determinant of the failure patients should be referred for heart
transplant evaluation. Although the results of transplantation in
failing single ventricle patients are not optimal, it represents the
last viable option for these patients and the final stage of treatment
for these patients (46, 47) and specially for HLHS. Many concern-
ing associated problems such as renal and hepatic dysfunction can
play a significant role in the outcomes. A progressive increase of




Kreutzer APA anastomosis and its variants
Bjork atrioventricular connections
History of prior long standing PA banding or shunts
Increases in pulmonary vascular resistances secondary to
Systemic atrioventricular valve disease (specially history of mitral atresia
or stenosis with restrictive-interatrial-communication)
Down’s syndrome
Long duration of prior systemic PA shunts or PA distortion
Living at high altitude (54, 55)
Detrimental effects of chronic use of amiodarone
Subclinical chronic micropulmonary embolism (36)
Pulmonary lymphatic edema (due to increased central venous
pressure) (56)
Chronic lack of pulsatile pulmonary flow (57).
Ventricular dysfunction
Prior long standing volume overload
Inadequate systemic ventricle (right or undetermined ventricle,
cardiomyopathy, or myocardial fibrosis according to the length of time
with chronic hypoxia)
Arrhythmia
AVV incompetence (more frequent in heterotaxy syndrome or HLHS)
Inadequate myocardial protection during prior operations
History of prior systemic out flow tract or arch obstructions treated with
PA banding
pulmonary vascular resistances after transplantation for the failing
Fontan palliation has also been reported (48).
Of note, there are not many patients who have reached over
50 years of age with a univentricular heart following Fontan
Kreutzer palliation. To have reached 50 years of age in 2013 means
that the patient was born before 1963, survived the initial palliative
procedures and the original Fontan Kreutzer palliation. Of the ini-
tial cohort of Buenos Aires among the 14 patients operated upon
by the early 70s, 5 are currently alive. All five with a dominant
left ventricle: four of these patients had tricuspid atresia and one
double inlet left ventricle. Both patients remain in good clinical
condition without conversion.
One of the survivors, who was the fifth case of the series pre-
sented at Toronto in 1975 (13), is a lady 56 years old (Figure 6A)
with TA Ib, who underwent an APA in 1975 at 17 years of age. She
is currently, to our knowledge the longest survivor in the world
after 39 years of FK palliation. In November 2007, her case was
published as a brief communication (49).
For 20 years after surgery this patient led a normal life. She got
married, had no pregnancies, and divorced. In the late follow-up
she developed intermittent atrial fibrillation and the homograft
became stenotic and calcified. She was treated with amiodarone
and anticoagulation, as she originally refused surgical conver-
sion. At age 49, she was overtly symptomatic, with hydrothorax
(Figure 6B), atrial fibrillation (Figure 7A), and a large intra atrial
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FIGURE 6 | (A) Patient aged 53 years with TA Ib. After 34 years of Fontan Kreutzer palliation. (B) Pre-reconversion chest Roentgenogram. (C) Chest
Roentgenogram 1 year after conversion.
FIGURE 7 | (A) Pre-reconversion ECG. (B) ECG 2 years after conversion. (C)
Treadmill test 2 years after conversion.
thrombus. Fortunately her left ventricular function was preserved.
Conversion to a fenestrated EC with extraction of homograft and
thrombus was performed on May 2006. Now, after 7 years fol-
lowing conversion, she is in good clinical condition (Figure 6C)
in sinus rhythm (Figure 7B) and with an exercise test achieving
seven METs (Figure 7C).
CONCLUSION
The durability of the suboptimal Fontan Kreutzer hemodynamic
system is affected by many variables, patient, procedural, and
management related. Several hypotheses could explain the dete-
rioration of this system with the passing of time, particularly in
patients with forms other than the “perfect” tricuspid atresia. Sev-
eral adverse factors may lead to chronic gradual increase in the
right side venous pressure: Table 1.
With the development of better surgical management, the out-
come of the FK procedure seems to have improved over the years.
The current long-term results using the modern surgical alterna-
tives are excellent (31, 32, 50–52). The challenge is to reproduce
this outcome for the vast majority of patients, and to develop viable
alternatives to deal with late failure.
As physicians involved in the care of the most complex form of
congenital heart disease, our future goal would be to seek a better
surgical procedure to improve the long-term outcome of patients
with UH. May it be a complete or partial mechanical device (53)
or improved heart transplantation availability and outcomes. In
the meantime, the Fontan Kreutzer palliation, which seemed to
be a radical approach in the 70s, has become a routine procedure
world wide, and continues to represent the best surgical option
we can offer to these patients. It is clearly, one of the triumphs of
cardiac surgery in congenital heart disease.
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